2′-Deoxy-2′-fluoroguanosine
Based on 1 publication(s) in Google Scholar
2′-Deoxy-2′-fluoroguanosine is a nucleoside analog and potent influenza virus inhibitor with an EC90 value of <0.35 μM against influenza A and B viruses. 2′-Deoxy-2′-fluoroguanosine inhibits influenza virus replication in the upper respiratory tract, thereby ameliorating fever and nasal inflammation.
For research use only. We do not sell to patients.
- Purity: 99.90%
- CAS No.: 78842-13-4
- Formula: C10H12FN5O4
- Molecular Weight:285.24
-
Storage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
HY-W013403
2'-Deoxy-2'-fluorouridine
-
HY-W012009
2'-Deoxy-2'-fluorocytidine
-
HY-17422
Acyclovir
-
HY-W039442
2′-Deoxy-2′-fluoroadenosine
-
HY-17422R
Acyclovir (Standard)
-
HY-14904A
Umifenovir hydrochloride
-
HY-17425A
Valacyclovir hydrochloride
-
HY-B0277
Vidarabine
-
HY-17425AR
Valacyclovir hydrochloride (Standard)
-
HY-14904AR
Umifenovir hydrochloride (Standard)
-
HY-B0004
Doxofylline
-
HY-109025
Baloxavir marboxil
Publications Citing Use of MedChemExpress (MCE) 2′-Deoxy-2′-fluoroguanosine
More
Biological Activity
EC90: <0.35 μM (influenza virus A and B)[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEp-2 | EC50 |
>200 μM
Compound: 2'd2'FG
|
Antiviral activity against RSV A2 infected in human Hep2 cells assessed as protection against virus-induced cytopathic effect after 4 days by Cell-Titer Glo assay
Antiviral activity against RSV A2 infected in human Hep2 cells assessed as protection against virus-induced cytopathic effect after 4 days by Cell-Titer Glo assay
|
[PMID: 25978965] |
| HEp-2 | IC50 |
6.6 μM
Compound: 2'd2'FG
|
Inhibition of RSV A2 RNA-dependent RNA polymerase expressed in human Hep2 cells using ATP, GTP, UTP, CTP and 1.5 uCi [alpha-32P] NTP as substrate assessed as reduction of total radiolabled transcript after 90 mins by agarose gel electrophoresis
Inhibition of RSV A2 RNA-dependent RNA polymerase expressed in human Hep2 cells using ATP, GTP, UTP, CTP and 1.5 uCi [alpha-32P] NTP as substrate assessed as reduction of total radiolabled transcript after 90 mins by agarose gel electrophoresis
|
[PMID: 25978965] |
| MT4 | CC50 |
>49 μM
Compound: 2'd2'FG
|
Cytotoxicity against human MT4 cells assessed as cell viability after 5 days by Cell-Titer Glo assay
Cytotoxicity against human MT4 cells assessed as cell viability after 5 days by Cell-Titer Glo assay
|
[PMID: 25978965] |
2′-Deoxy-2′-fluoroguanosine (10 μM) blocks primary and secondary transcription of influenza virus X31 strain RNA in chicken embryo cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 78842-13-4
-
Appearance Solid
-
Molecular Weight 285.24
-
Formula C10H12FN5O4
-
Color White to off-white
-
SMILES
OC[C@@H]1[C@@H](O)[C@@H](F)[C@H](N2C(NC(N)=NC3=O)=C3N=C2)O1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
ACS Infect Dis
Targeting the Rift Valley Fever Virus Polymerase: Resistance Mechanisms and Structural Insights. [Abstract]2025 Oct 30. PMID: 41166549
Solvent & Solubility
DMSO : 50 mg/mL (175.29 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (8.76 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (8.76 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (277 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
[1]. Tisdale M, et, al. Inhibition of influenza virus transcription by 2'-deoxy-2'-fluoroguanosine. Antimicrob Agents Chemother. 1995 Nov;39(11):2454-8. [Content Brief]
[2]. Jakeman KJ, et, al. Efficacy of 2'-deoxy-2'-fluororibosides against influenza A and B viruses in ferrets. Antimicrob Agents Chemother. 1994 Aug;38(8):1864-7. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.5058 mL | 17.5291 mL | 35.0582 mL | 87.6455 mL |
| 5 mM | 0.7012 mL | 3.5058 mL | 7.0116 mL | 17.5291 mL | |
| 10 mM | 0.3506 mL | 1.7529 mL | 3.5058 mL | 8.7645 mL | |
| 15 mM | 0.2337 mL | 1.1686 mL | 2.3372 mL | 5.8430 mL | |
| 20 mM | 0.1753 mL | 0.8765 mL | 1.7529 mL | 4.3823 mL | |
| 25 mM | 0.1402 mL | 0.7012 mL | 1.4023 mL | 3.5058 mL | |
| 30 mM | 0.1169 mL | 0.5843 mL | 1.1686 mL | 2.9215 mL | |
| 40 mM | 0.0876 mL | 0.4382 mL | 0.8765 mL | 2.1911 mL | |
| 50 mM | 0.0701 mL | 0.3506 mL | 0.7012 mL | 1.7529 mL | |
| 60 mM | 0.0584 mL | 0.2922 mL | 0.5843 mL | 1.4608 mL | |
| 80 mM | 0.0438 mL | 0.2191 mL | 0.4382 mL | 1.0956 mL | |
| 100 mM | 0.0351 mL | 0.1753 mL | 0.3506 mL | 0.8765 mL |
2′-Deoxy-2′-fluoroguanosine Related Classifications
HY-W011518 Related Classifications
Powered by Bioz